Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 240 descriptions
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 000000000 | - | - | - | - | [1] 66 66 💬1. 000000000
| ||||||||||
| 2 | A-623 or AMG 623 | - | - | - | - | [1] 66 66 💬2. A-623 or AMG 623
| ||||||||||
| 3 | A07EA06 | - | - | - | - | [1] 66 66 💬3. A07EA06
| ||||||||||
| 4 | Abelmoschus manihot | - | - | - | - | [1] 66 66 💬4. Abelmoschus manihot
| ||||||||||
| 5 | ACE inhibitor | - | - | - | - | [1] 66 66 💬5. ACE inhibitor
| ||||||||||
| 6 | ACE inhibitor + statin | - | - | - | - | [1] 66 66 💬6. ACE inhibitor + statin
| ||||||||||
| 7 | ACE Inhibitor or Angiotensin receptor antagonist | [1] Angiotensin II Angiotensin II | [2] Angiotensin II
Angiotensin II
,Angiotensin II 💬 7. ACE Inhibitor or Angiotensin receptor antagonist
| [2] AGTR1 AGTR1,AGTR2 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, A ... | [1] 66 66 💬7. ACE Inhibitor or Angiotensin receptor antagonist
| ||||||||||
| 8 | ACE/ARB | - | - | - | - | [1] 66 66 💬8. ACE/ARB
| ||||||||||
| 9 | ACEi | - | - | - | - | [2] 66 66, 224 💬
| ||||||||||
| 10 | ACEI/ARB and corticosteroids | - | - | - | - | [1] 66 66 💬10. ACEI/ARB and corticosteroids
|